SEROLOGICAL BIOMARKERS OF TYPE III AND IV COLLAGEN REMODELING PREDICT AND MONITOR INFLIXIMAB TREATMENT RESPONSE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

Marta Sorokina Alexdóttir  1     Arno R. Bourgonje  2     Anne-Christine Bay-Jensen  1     Klaas Nico Faber  2     Morten Asser Karsdal  1     Roberta Loveikyte  3     Hendrik M. van Dullemen     Marijn C. Visschedijk     Eleonora A. M. Festen     Rinse K. Weersma     Gerard Dijkstra     Joachim Mortensen    
1 Nordic Bioscience,Herlev,Denmark
2 University of Groningen, University Medical Center Groningen,Groningen,Netherlands
3 University of Groningen, University Medical Center Groningen,Groni

Session
IBD (Posters)

Citation
United European Gastroenterology Journal 2021; 9 (Supplement 1)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing